Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7521-7530 of 13157

Page
per page
  1. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  2. Bafilomycin C1
    C4729 Bafilomycin C1
    Summary: vacuolar H+-ATPases (V-ATPases) inhibitor
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  3. Darglitazone
    C4758 Darglitazone
    Summary: PPARγ agonist with antidiabetic actions
      ≤5 mg/mL
  4. p-nitro-Cyclic Pifithrin-α
    C5104 p-nitro-Cyclic Pifithrin-α
    Summary: inactivator of p53
      ≤1 mg/mL
  5. Mutant EGFR inhibitor
    B1103 Mutant EGFR inhibitor
    Summary: Selective Mutated EGFR inhibitor
      Soluble in DMSO
  6. Lafutidine
    B1575 Lafutidine
    Summary: Histamine H2-receptor antagonist
      insoluble in H2O; ≥21.58 mg/mL
  7. AS-252424
    B2180 AS-252424
    Target: Akt|PI3K
    Summary: PI3Kγ inhibitor,novel and potent
      insoluble in EtOH; insoluble in H2O; ≥30.5 mg/mL
  8. Oxymetazoline HCl
    B1342 Oxymetazoline HCl
    Summary: Alpha-1/alpha-2 agonist
      Soluble in DMSO
  9. Raltitrexed
    B1476 Raltitrexed
    Target: Thymidylate Synthase
    Summary: Thymidylate synthase inhibitor
      insoluble in H2O; ≥154 mg/mL
  10. Noradrenaline bitartrate monohydrate
    B1990 Noradrenaline bitartrate monohydrate
    Summary: Adrenergic receptor agonist
      insoluble in EtOH; ≥11.35 mg/mL

Items 7521-7530 of 13157

Page
per page